| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |